AACC sees rise in impact of medical laboratory journal

LabPulse.com staff writers
Jul 20, 2022
2021 09 27 17 08 8174 Diagnostic Analyzer Lab Pcr 400

AACC recently announced that the impact factor of its journal Clinical Chemistry has risen to 12.167 in the 2021 Clarivate Journal Citation Reports.

The impact factor places it in the top 2% of 21,430 ranked academic journals and reaffirms that it is the top journal on medical laboratory technology, AACC said.

It noted that Clinical Chemistry has disseminated essential research on all aspects of coronavirus testing and a broad range of medical conditions.

A journal's impact factor is determined using the number of citations received in that year by articles published in the journal during the two preceding years, and is calculated by Clarivate Analytics (formerly known as Thomson Reuters).

Latest in Guideline
Bacteria Mycobacterium Tuberculosis Social
WHO launches new guidance on TB diagnostics
March 21, 2024
Visit our Molecular Diagnostics Community
Sponsored
Visit our Molecular Diagnostics Community
April 5, 2024
Fda Button Social
FDA orders new info warnings on CAR-T therapies
January 30, 2024
Regulation Wheel Social
Labs and manufacturers face challenges with rollout of IVDR
October 2, 2023
Related Stories
2021 04 19 16 59 1236 Fingerprick Blood 400
Guideline
Mercy Research to offer Grail multicancer blood test
2021 06 07 23 26 6198 Blood Tube Tumor Marker Test 400
Guideline
Fountain Health Insurance to cover Grail multicancer test
2020 03 03 23 13 0226 Hepatitis C Virus 400
Guideline
Study: less than half of pregnant people screened for HCV
Visit our Molecular Diagnostics Community
Sponsor Content
Visit our Molecular Diagnostics Community
More in Guideline
WHO launches new guidance on TB diagnostics
By LabPulse.com staff writers
The World Health Organization has published updated guidance for the diagnosis of tuberculosis (TB), including new recommendations on the use of next-generation sequencing for the diagnosis of drug-resistant TB.
March 21, 2024
Bacteria Mycobacterium Tuberculosis Social
FDA updates draft guidance for Alzheimer's drug development biomarkers
By LabPulse.com staff writers
The U.S. Food and Drug Administration (FDA) has released an updated draft guidance for the use of biomarkers aimed at sponsors and pharmaceutical companies developing drugs intended to treat early Alzheimer's disease.
March 14, 2024
Amyloid Plaque Alzheimer Social
FDA orders new info warnings on CAR-T therapies
By LabPulse.com staff writers
Following its review of reports of T-cell malignancies associated with the administration of six CAR-T immunotherapies, the FDA has instructed the manufacturers to include warnings in the prescribing info for the therapeutics.
January 30, 2024
Fda Button Social
Labs and manufacturers face challenges with rollout of IVDR
By Matt Limb
Laboratories and medical device manufacturers have revealed how they face technical and workload challenges in gearing up to comply with stringent new European Union regulations.
October 2, 2023
Regulation Wheel Social
USP proposes synthetic alternative to horseshoe crab blood in endotoxin testing
By Nick Paul Taylor
The U.S. Pharmacopoeia (USP) has published draft guidelines on using a synthetic alternative to reagents derived from horseshoe crabs, advancing efforts to provide an alternative way of performing endotoxin testing.
August 31, 2023
Lab Blood Man Social
NGS working group provides recommendations for germline variant confirmation
By Elissa Wolfson
A joint report provides eight recommendations for standardizing orthogonal confirmation practices for germline variants detected by next-generation sequencing.
May 19, 2023
Dna Sequencing2 Social
NCI study outlines challenges, opportunities in achieving Cancer Moonshot goals
By Elissa Wolfson
A National Cancer Institute study outlined challenges and opportunities in achieving President Biden’s Cancer Moonshot goal -- a 50% reduction in U.S. cancer death rates by 2047.
April 18, 2023
Cancer Cell Target2 Social
Report identifies bias factors in clinical genetic testing
By Nick Paul Taylor
ACMG committees worked together on a points-to-consider report in light of the potential for clinical, technical, and environmental biases to influence equitable access to clinical genetics testing.
April 14, 2023
Eye Dna Genes Social
AACC provides recommendations for detecting cervical cancer
By LabPulse.com staff writers
The guidance aims to update healthcare and laboratory medicine professionals about the latest advancements in this field, and to help them select the most effective cervical cancer detection strategy for their patients, AACC said.
March 6, 2023
Squamous Epithelial Cells Cervical Social
Agendia MammaPrint UltraLow Risk gene signature recognized in updated NCCN guidelines
By LabPulse.com staff writers
The MammaPrint 70-gene signature identifies patients at low or high risk of distant recurrence within five years of a breast cancer diagnosis.
February 13, 2023
Breast Cancer2 Social
Study suggests race adjustment unnecessary for alpha fetoprotein prenatal testing
By Elissa Wolfson
Researchers recommend that a longstanding race-based adjustment to test-result values of alpha fetoprotein from a common prenatal screening should be discontinued.
February 6, 2023
Blood Test Samples Lab Social
OIG report outlines challenges with CDC-supported COVID-19 vaccination programs
By Leo O'Connor
There were challenges with "vaccine logistics, such as large minimum order sizes for vaccines, requirements for ultra-cold storage, and insufficient ancillary supplies," OIG said.
January 31, 2023
Vaccine Choices Sars Co V 2 Social
Page 1 of 9
Next Page